Quarter
Charts
🇺🇸US Markets

Viavi Solutions Inc.

VIAV

CIK 0000912093 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-27) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$369M
↑+36.4% +$99Mvs FY2024 (Q4)
Operating Income
$11M
↓-48.6% -$11Mvs FY2024 (Q4)
Gross Profit
$211M
↑+31.0% +$50Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
53/100
  • Profitability
    0ROIC 4.4% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 2.61 (above 1.5 = solid)
  • Leverage
    27D/E 1.46 (under 0.5 = conservative)
  • Efficiency
    27Asset Turnover 0.55x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +36.4% (10% = solid, 25%+ = elite)
  • Margin Trend
    62Op Margin 3.1% · trend +0.7pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project VIAV's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -16.3%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$3.83
Total enterprise IV
$866M
Diluted shares
0.23B
Terminal PV
$610M (70% of total)
Year-5 FCF
$72M
YearProjected FCFDiscounted PV
+1$64M$58M
+2$66M$54M
+3$68M$51M
+4$70M$48M
+5$72M$45M
Terminal$982M$610M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$26M
investment in PP&E
Stock buybacks (TTM)
$30M
share count reduction
Stock-based comp (TTM)
$54M
non-cash dilution

Balance sheet · 2025-12-27

latest filed snapshot
Total assets
$2.78B
everything owned
Total liabilities
$1.94B
everything owed
Stockholders' equity
$834M
shareholder claim
Net debt
$456M
LT debt minus cash

Recent performance · 66 quarters

Revenue↑+36.4% +$99M
$369M
Net Income↓-628.6% -$57M
$-48M
Free Cash Flow↑+1.1% +$400K
$37M
Operating Margin↓-5.1pts
3.1%

Drill down